Wed, May 14, 8:34 PM (29 days ago)
**Oaktree Acquisition Corp. III Life Sciences (OACCU) Q1 2025 Financial Summary** **Financial Health and Performance:** - **Revenue:** No operating revenue generated; non-operating income from interest on trust account. - **Profit Margins:** Net income of $1,658,791 primarily from interest earned on cash held in the trust account. - **Cash Flow:** Net cash used in operating activities was $75,561. Cash held in the trust account was $195,682,615. - **Earnings Changes:** Net income per share for redeemable Class A ordinary shares was $0.07. **Quarterly Performance Discussion:** - **Operational Status:** No operations or revenues; focus on identifying a target business for a merger or acquisition. - **Cash Management:** $191,990,290 placed in the trust account from the initial public offering (IPO) and private placement units. - **Expenses:** General and administrative expenses were $444,802. **Trends and Uncertainties:** - **Market Risks:** Geopolitical tensions and economic sanctions may impact the ability to complete a business combination. - **Future Operations:** Dependent on completing a business combination within 24 months; potential for additional financing or loans from sponsors. **Future Operations Impact:** - **Business Combination:** Success depends on identifying and completing a merger or acquisition. - **Financial Resources:** Trust account funds and potential loans from sponsors will support operations until a business combination is completed. **Ticker:** OACCU **Note:** Amounts are in thousands, 000s.